Get started

Stockstrading

GRAY Technical Analysis 🧙 Graybug Vision Inc is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. The company's products under pipeline are GB-102, for the treatment of wet age-related macular degeneration, or wet AMD, and diabetic macular edema, or DME; GB-103; and GB-401. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
GLong
by yura_trades
$AMT Announces Pricing of Public Offering of Common StockApplied Molecular Transport Announces Proposed Public Offering of Common Stock AMT announced that it has commenced an underwritten public offering of 2,500,000 shares of its common stock. All of the shares in the proposed offering will be sold by AMT. In addition, AMT expects to grant the underwriters a 30-day option to purchase up to an additional 375,000 shares of its common stock in the offering. Applied Molecular Transport Announces Pricing of Public Offering of Common Stock AMT today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a public offering price of $42.00 per share.
A
by AlenCiken
3
$Uxin Entry into a Binding Term Sheet with Potential InvestorsUxin Announces Entry into a Binding Term Sheet with Potential Investors $UXIN, a leading nationwide online used car dealer in China, today announced that it has entered into a binding term sheet with two established Asian funds on April 1, 2021, pursuant to which the potential investors have agreed to negotiate and potentially enter into definitive agreements with the Company for the subscription of senior convertible preferred shares. The potential transaction has an aggregate investment amount of potentially up to US$300 million. The completion of the potential transaction is subject to the parties’ execution of definitive agreements and customary closing conditions to be stipulated therein. finance.yahoo.com
NASDAQ:UXIN
by AlenCiken
$JFIN appear to be rising on news or speculation regarding NFTsShares of $JFIN appear to be rising on news or speculation regarding NFTs. For those of you that don't know, NFTs are digital files such as art, video, audio, and other files stored on blockchain, which is the digital ledger technology that powers cryptocurrencies like Bitcoin. Some NFTs have already sold for millions of dollars. Jiayin appear to be linked to speculation that the company may eventually jump into the NFT space. Jiayin is an online individual loan marketplace that seeks to reach underserved customers in China. However, recent buzz on Twitter has people saying the company could potentially get into the NFT space, although there is no real news pointing to that right now. The hype and potential around NFT is certainly at an all-time high and eerily reminiscent of when cryptocurrencies, which are also powered by blockchain, first gained mass popularity several years ago. I would advise caution on anything related to NFTs. While they certainly have taken off in recent months, we are still in very days where the market for these assets will likely remain extremely volatile for quite some time. www.fool.com
NASDAQ:JFIN
by AlenCiken
$TKAT surged yesterday due to hype in NFT art?The Hong Kong-based online art trading platform rose prompted by increased attention from social media amid frenzy surrounding non-fungible tokens. NFTs are akin to a digital certificate of ownership. Takung provides collectors a way to jointly own Asian and other fine arts including paintings, calligraphies, jewelry, and precious gems, according to its website. The hype in NFT art ranging from sneakers to memes have been in the focus of late and a piece from Beeple — “The First 5000 Days” — commanded price tags of millions of dollars. Tesla Inc TSLA CEO Elon Musk also jumped on the bandwagon and put an NFT song — on NFTs — for sale, which the artist Beeple offered to purchase for $69 million, but later changed his mind. www.benzinga.com
T
by AlenCiken
$SVRA Announces Closing of $130 Million Public OfferingSavara Announces Pricing of Public Offering of Common Stock $SVRA today announced the pricing of an underwritten public offering of 45,785,828 shares of its common stock at a price to the public of $1.45 per share. As a component of the offering, in lieu of shares of common stock, Savara offered to certain existing investors pre-funded warrants to purchase an aggregate of 32,175,172 shares of common stock at a purchase price of $1.449 per warrant, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each pre-funded warrant. finance.yahoo.com Savara Announces Closing of $130 Million Public Offering Following Full Exercise of Underwriters’ Option finance.yahoo.com
NASDAQ:SVRA
by AlenCiken
Bayer pharmaceutical stock long term buy opportunityBayer stock is a life science company trading on the German stock exchanges with the symbol BAYN. The Company’s segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and speciality therapeutics, especially in the areas of cardiology, oncology, gynaecology, haematology and ophthalmology, as well as radio-pharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter. Bayer AG stock is a German company trading in the German Stock Exchange. It is one of the biggest and most important pharmaceutical companies in the world. I doubt that you’ve never heard from Bayer AG, because its products range from the famous Aspirin to even “more popular” Viagra 🙂 Now, I believe you are probably smiling and remembering this company 🙂 Before starting to write this blog post on Bayer, I googled the company name to try and find some extra information I could add, that would either support or negate the strong rally we are expecting on this particular pharmaceutical German stock.
XETR:BAYNLong
by AlfonsoMoreno
AHPI Technical Analysis 🧙Allied Healthcare Products Inc is a US-based company. It mainly manufactures a variety of respiratory products used in the healthcare industry in a wide range of hospital and alternate site settings, including sub-acute care facilities, home health care, and emergency medical care. The product line of the company includes respiratory anesthesia products, home respiratory care products, medical gas system construction products, medical gas system regulation devices, disposable oxygen, and specialty gas cylinders, portable suction equipment, trauma, and patient handling products, respiratory products, and others. The company markets its products under various brand names Timeter, Carbolime, Litholyme, Schuco, Chemetron, Oxequip, Lif-O-Gen, Gomco, and others. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ALong
by yura_trades
$50 MILLION REGISTERED DIRECT OFFERING case study$VISL ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES $VISL today announced that it has entered into a definitive agreement with institutional investors for the purchase and sale of 18,181,820 shares of its common stock and common stock warrants to purchase up to 9,090,910 shares of common stock at a combined purchase price of $2.75 per share in a registered direct offering. The common stock warrants will be immediately exercisable, have an exercise price of $3.25 per share and will expire five years from the date of issuance. The closing of the offering is expected to occur on or about February 8, 2021, subject to the satisfaction of customary closing conditions. finance.yahoo.com ANNOUNCES CLOSING OF $50 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES finance.yahoo.com What we can learn from the registered direct offerings?
NASDAQ:VISL
by AlenCiken
1